Suchergebnisse - (Subject:"Adalimumab")

PubPharm (7.194)

1

Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era : A Narrative Review

enthalten in: Advances in therapy | 2024

von Allegretti, J. | Brady, J. | Wicker, A. | +2

2

Synergistic promotion of transient transgene expression in CHO cells by PDI/XBP-1s co-transfection and mild hypothermia

enthalten in: Bioprocess and biosystems engineering | 2024

von Zhang, X. | Wang, Y. | Yi, D. | +6

3

A TNF-α inhibitor abolishes sepsis-induced cognitive impairment in mice by modulating acetylcholine and nitric oxide homeostasis, BDNF release, and neuroinflammation

enthalten in: Behavioural brain research | 2024

von Öz, M. | Erdal, H.

4

Clonal T lymphocytosis resolution after adalimumab discontinuation

enthalten in: Medicina clinica | 2024

von Alonso Trillo, R. | García Vela, J.

5

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Verstockt, B. | Pivorunas, V. | Al Mahi, N. | +10

6

Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy

enthalten in: Journal of Crohn's & colitis | 2024

von Wieringa, J. | Kruizinga, M. | Driessen, G. | +2

7

Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA) : does duration matter?

enthalten in: Clinical rheumatology | 2024

von Teh, K. | Das, L. | Book, Y. | +3

8

Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease : A Multicenter Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von McCurdy, J. | Munir, J. | Parlow, S. | +17

9

Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Aarts, P. | van Huijstee, J. | van der Zee, H. | +2

10

'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

enthalten in: Advances in therapy | 2024

von Gaylis, N. | Both, C. | Lemke, L. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[720]